Literature DB >> 25037631

The molecular mechanism of species-specific recognition of lipopolysaccharides by the MD-2/TLR4 receptor complex.

Alja Oblak1, Roman Jerala2.   

Abstract

Lipid A, a component of bacterial lipopolysaccharide, is a conserved microbe-associated molecular pattern that activates the MD-2/TLR4 receptor complex. Nevertheless, bacteria produce lipid A molecules of considerable structural diversity. The human MD-2/TLR4 receptor most efficiently recognizes hexaacylated bisphosphorylated lipid A produced by enterobacteria, but in some animal species the immune response can be elicited also by alternative lipid A varieties, such as tetraacylated lipid IVa or pentaacylated lipid A of Rhodobacter spheroides. Several crystal structures revealed that hexaacylated lipid A and tetraacylated lipid IVa activate the murine MD-2/TLR4 in a similar manner, but failed to explain the antagonistic vs. agonistic activity of lipid IVa in the human vs. equine receptor, respectively. Targeted mutagenesis studies of the receptor complex revealed intricate combination of electrostatic and hydrophobic interactions primarily within the MD-2 co-receptor, but with a contribution of TLR4 as well, that contribute to species-specific recognition of lipid A. We will review current knowledge regarding lipid A diversity and species-specific activation of the MD-2/TLR4 receptor complex in different species (e.g. human, mouse or equine) by lipid A varieties.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Innate immunity; Lipid A; Lipopolysaccharide; MD-2; Selectivity; TLR4

Mesh:

Substances:

Year:  2014        PMID: 25037631     DOI: 10.1016/j.molimm.2014.06.034

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  22 in total

1.  MD-2 as the target of a novel small molecule, L6H21, in the attenuation of LPS-induced inflammatory response and sepsis.

Authors:  Yi Wang; Xiaoou Shan; Gaozhi Chen; Lili Jiang; Zhe Wang; Qilu Fang; Xing Liu; Jingying Wang; Yali Zhang; Wencan Wu; Guang Liang
Journal:  Br J Pharmacol       Date:  2015-07-21       Impact factor: 8.739

2.  Safe Recombinant Outer Membrane Vesicles that Display M2e Elicit Heterologous Influenza Protection.

Authors:  Hannah C Watkins; C Garrett Rappazzo; Jaclyn S Higgins; Xiangjie Sun; Nicole Brock; Annie Chau; Aditya Misra; Joseph P B Cannizzo; Michael R King; Taronna R Maines; Cynthia A Leifer; Gary R Whittaker; Matthew P DeLisa; David Putnam
Journal:  Mol Ther       Date:  2017-02-16       Impact factor: 11.454

3.  Identification of generic and pathogen-specific cord blood monocyte transcriptomes reveals a largely conserved response in preterm and term newborn infants.

Authors:  Emma de Jong; David G Hancock; Julie Hibbert; Christine Wells; Peter Richmond; Karen Simmer; David Burgner; Tobias Strunk; Andrew J Currie
Journal:  J Mol Med (Berl)       Date:  2017-11-13       Impact factor: 4.599

4.  Tracing the evolution of novel features of human Toll-like receptor 4.

Authors:  Jeremy A Anderson; Andrea N Loes; Grace L Waddell; Michael J Harms
Journal:  Protein Sci       Date:  2019-06-03       Impact factor: 6.725

5.  Genome-wide association study of new-onset atrial fibrillation after coronary artery bypass grafting surgery.

Authors:  Miklos D Kertai; Yi-Ju Li; Yunqi Ji; Wenjing Qi; Frederick W Lombard; Svati H Shah; William E Kraus; Mark Stafford-Smith; Mark F Newman; Carmelo A Milano; Nathan Waldron; Mihai V Podgoreanu; Joseph P Mathew
Journal:  Am Heart J       Date:  2015-06-17       Impact factor: 4.749

6.  Studies of the TLR4-associated protein MD-2 using yeast-display and mutational analyses.

Authors:  Daiva M Mattis; Adam S Chervin; Diana R Ranoa; Stacy L Kelley; Richard I Tapping; David M Kranz
Journal:  Mol Immunol       Date:  2015-08-28       Impact factor: 4.407

7.  Cardiolipins Act as a Selective Barrier to Toll-Like Receptor 4 Activation in the Intestine.

Authors:  Stephen R Coats; Ahmed Hashim; Nikolay A Paramonov; Thao T To; Michael A Curtis; Richard P Darveau
Journal:  Appl Environ Microbiol       Date:  2016-06-30       Impact factor: 4.792

8.  Evidence that angiotensin II does not directly stimulate the MD2-TLR4 innate inflammatory pathway.

Authors:  Charles C Okechukwu; Nancy T Pirro; Mark C Chappell
Journal:  Peptides       Date:  2020-11-09       Impact factor: 3.750

9.  MD-2 determinants of nickel and cobalt-mediated activation of human TLR4.

Authors:  Alja Oblak; Jelka Pohar; Roman Jerala
Journal:  PLoS One       Date:  2015-03-24       Impact factor: 3.240

10.  Critical residues involved in Toll-like receptor 4 activation by cationic lipid nanocarriers are not located at the lipopolysaccharide-binding interface.

Authors:  Caroline Lonez; Kate L Irvine; Malvina Pizzuto; Boris I Schmidt; Nick J Gay; Jean-Marie Ruysschaert; Monique Gangloff; Clare E Bryant
Journal:  Cell Mol Life Sci       Date:  2015-05-09       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.